cabozantinib for radioiodine-refractory differentiated thyroid cancer with dr. sherman
Published 2 years ago • 353 plays • Length 55:43Download video MP4
Download video MP3
Similar videos
-
0:43
cabozantinib's targeting potential
-
34:22
radioactive iodine (rai) therapy for rai-refractory disease: “redifferentiation” with dr. sherman
-
4:09
cosmic-311: cabozantinib versus placebo in patients with radioiodine-refractory differentiated t...
-
1:30
cabozantinib conclusions
-
59:27
combination of lenvantinib and pembrolizumab for thyroid cancer with dr. bryan haugen
-
1:01:01
resensitizing thyroid tumors to radioactive iodine with dr. naifa busaidy
-
2:41
dr. sherman comments on cabozantinib and vandetanib in medullary thyroid cancer
-
58:32
defining advanced thyroid cancer & its targeted treatment with dr. shonka
-
1:02:32
selumetinib plus adjuvant radioactive iodine with dr. alan ho
-
1:30
dr. sherman on selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
-
1:00:49
selective use of radioactive therapy for ptcs with dr. giorgio grani
-
1:01:53
retrospective study validating predictors of differentiated thyroid cancer w/ dr. wijewardene
-
0:56
dr. steven sherman defines rai resistance in thyroid cancer
-
1:34
dr. eric sherman on the sequencing of cabozantinib and vandetanib for mtc
-
21:16
precision medicine advances in thyroid cancer – management of advanced rai refractory
-
2:20
dr. sherman on pazopanib in anaplastic thyroid cancer
-
1:08:06
thyroid cancer: q & a on treatments, side effects, new therapies. drs. sherman & tuttle
-
0:59
dr. ezra cohen discusses the cabozantinib exam trial
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability